Wang Shujin, Han Yinying, Nabben Miranda, Neumann Dietbert, Luiken Joost J F P, Glatz Jan F C
Institute of Life Sciences, Chongqing Medical University, Chongqing 400032, China.
Department of Genetics & Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200 MD Maastricht, The Netherlands.
Metabolites. 2022 Jun 22;12(7):579. doi: 10.3390/metabo12070579.
The heart is a metabolically flexible omnivore that can utilize a variety of substrates for energy provision. To fulfill cardiac energy requirements, the healthy adult heart mainly uses long-chain fatty acids and glucose in a balanced manner, but when exposed to physiological or pathological stimuli, it can switch its substrate preference to alternative substrates such as amino acids (AAs) and ketone bodies. Using the failing heart as an example, upon stress, the fatty acid/glucose substrate balance is upset, resulting in an over-reliance on either fatty acids or glucose. A chronic fuel shift towards a single type of substrate is linked with cardiac dysfunction. Re-balancing myocardial substrate preference is suggested as an effective strategy to rescue the failing heart. In the last decade, we revealed that vacuolar-type H-ATPase (v-ATPase) functions as a key regulator of myocardial substrate preference and, therefore, as a novel potential treatment approach for the failing heart. Fatty acids, glucose, and AAs selectively influence the assembly state of v-ATPase resulting in modulation of its proton-pumping activity. In this review, we summarize these novel insights on v-ATPase as an integrator of nutritional information. We also describe its exploitation as a therapeutic target with focus on supplementation of AA as a nutraceutical approach to fight lipid-induced insulin resistance and contractile dysfunction of the heart.
心脏是一种代谢灵活的“杂食者”,能够利用多种底物来提供能量。为满足心脏的能量需求,健康的成年心脏主要以平衡的方式利用长链脂肪酸和葡萄糖,但在受到生理或病理刺激时,它可以将底物偏好切换为替代底物,如氨基酸(AAs)和酮体。以衰竭心脏为例,在应激状态下,脂肪酸/葡萄糖底物平衡被打破,导致对脂肪酸或葡萄糖的过度依赖。向单一类型底物的慢性燃料转变与心脏功能障碍有关。重新平衡心肌底物偏好被认为是挽救衰竭心脏的有效策略。在过去十年中,我们发现液泡型H-ATP酶(v-ATP酶)作为心肌底物偏好的关键调节因子发挥作用,因此,它是治疗衰竭心脏的一种新的潜在治疗方法。脂肪酸、葡萄糖和氨基酸选择性地影响v-ATP酶的组装状态,从而调节其质子泵活性。在这篇综述中,我们总结了关于v-ATP酶作为营养信息整合者的这些新见解。我们还描述了将其开发为治疗靶点的情况,重点是补充氨基酸作为一种营养治疗方法,以对抗脂质诱导的胰岛素抵抗和心脏收缩功能障碍。